Capital
Capital follows the restructuring.
Restructuring work produces shareholdings, assets and investor contacts that never reach the open market.
Capital and financing
We analyse the project and the underlying assets, structure bridge and growth financing, and approach the investors the structure actually suits — through to completion.
- Analysis of project, assets and security position
- Structuring of bridge and growth financing
- Approaching suitable investors from our own network
- Running the negotiation through to completion
Shareholdings and succession
Shareholder exits, share transfers and succession within the shareholder group — particularly where operational management is to remain untouched.
- Exit of individual shareholders without operational disruption
- Share transfers on an agreed valuation basis
- Succession solutions inside and outside the family
- Minority participations as an alternative to a sale
Portfolio and assets
Valuation and disposal of non-core assets in a pharmaceutical context — marketing authorisations and dossiers, product lines, brands, holdings. A discreet approach rather than an open market process.
- Authorisations and dossiers, individually or as a package
- Product lines with an existing manufacturing relationship
- Brands and rights with no active marketing
- Minority and silent positions
Process
How a process runs.
- 01
Valuation
We value the asset on authorisation status, manufacturability and market access — not on book value.
- 02
Buyer selection
A small number of addresses is selected from the network, each with a strategic fit. No broad distribution, no teaser in circulation.
- 03
Bid process
A structured process with firm deadlines, a data room and communication routed through one point.
- 04
Closing
Negotiation and handover run through to completion, together with counsel on both sides.
TB CAP does not provide regulated financial services, legal advice or tax advice. We act solely within an advisory relationship and work alongside our clients' law firms and tax advisers.